|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Organization WH and Kurman RJ: WHO
classification of tumours of female reproductive organs. Internat
Agency for Research on Cancer. 2014.
|
|
3
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Ann Rev
Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar
|
|
4
|
Savagner P, Yamada KM and Thiery JP: The
zinc-finger protein slug causes desmosome dissociation, an initial
and necessary step for growth factor-induced epithelial-mesenchymal
transition. J Cell Biol. 137:1403–1419. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gravdal K, Halvorsen OJ, Haukaas SA and
Akslen LA: A switch from E-cadherin to N-cadherin expression
indicates epithelial to mesenchymal transition and is of strong and
independent importance for the progress of prostate cancer. Clin
Cancer Res. 13:7003–7011. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hader C, Marlier A and Cantley L:
Mesenchymal-epithelial transition in epithelial response to injury:
The role of Foxc2. Oncogene. 29:1031–1040. 2010. View Article : Google Scholar :
|
|
8
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jannot G and Simard M: Tumour-related
microRNAs functions in Caenorhabditis elegans. Oncogene.
25:6197–6201. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar
|
|
11
|
Huang YW, Liu JC, Deatherage DE, Luo J,
Mutch DG, Goodfellow PJ, Miller DS and Huang TH: Epigenetic
repression of microRNA-129-2 leads to overexpression of SOX4
oncogene in endometrial cancer. Cancer Res. 69:9038–9046. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsuruta T, Kozaki K, Uesugi A, Furuta M,
Hirasawa A, Imoto I, Susumu N, Aoki D and Inazawa J: miR-152 is a
tumor suppressor microRNA that is silenced by DNA hypermethylation
in endometrial cancer. Cancer Res. 71:6450–6462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vandenboom Ii TG, Li Y, Philip PA and
Sarkar FH: MicroRNA and cancer: Tiny molecules with major
implications. Curr Genomics. 9:97–109. 2008. View Article : Google Scholar
|
|
14
|
Wei Y, Sun J and Li X: MicroRNA-215
enhances invasion and migration by targeting retinoblastoma tumor
suppressor gene 1 in high-grade glioma. Biotechnol Lett.
39:197–205. 2017. View Article : Google Scholar
|
|
15
|
Ohyashiki K, Umezu T, Katagiri S,
Kobayashi C, Azuma K, Tauchi T, Okabe S, Fukuoka Y and Ohyashiki
JH: Downregulation of Plasma miR-215 in chronic myeloid leukemia
patients with successful discontinuation of imatinib. Int J Mol
Sci. 17:5702016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li N, Zhang QY, Zou JL, Li ZW, Tian TT,
Dong B, Liu XJ, Ge S, Zhu Y, Gao J and Shen L: miR-215 promotes
malignant progression of gastric cancer by targeting RUNX1.
Oncotarget. 7:4817–4828. 2016.
|
|
17
|
Ulloa L, Creemers JW, Roy S, Liu S, Mason
J and Tabibzadeh S: Lefty proteins exhibit unique processing and
activate the MAPK pathway. J Biol Chem. 276:21387–21396. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cornet PB, Picquet C, Lemoine P, Osteen
KG, Bruner-Tran KL, Tabibzadeh S, Courtoy PJ, Eeckhout Y, Marbaix E
and Henriet P: Regulation and Function of LEFTY-A/EBAF in the human
endometrium mRNA expression during the menstrual cycle, control by
progesterone, and effect on matrix metalloproteinases. J Biol Chem.
277:42496–42504. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ulloa L and Tabibzadeh S: Lefty inhibits
receptor-regulated Smad phosphorylation induced by the activated
transforming growth factor-beta receptor. J Biol Chem.
276:21397–21404. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Salker MS, Christian M, Steel JH, Nautiyal
J, Lavery S, Trew G, Webster Z, Al-Sabbagh M, Puchchakayala G,
Föller M, et al: Deregulation of the serum- and
glucocorticoid-inducible kinase SGK1 in the endometrium causes
reproductive failure. Nat Med. 17:1509–1513. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alowayed N, Salker MS, Zeng N, Singh Y and
Lang F: LEFTY2 controls migration of human endometrial cancer cells
via focal adhesion kinase activity (FAK) and miRNA-200a. Cell
Physiol Biochem. 39:815–826. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Z, Dai Y, Dong Z, Li M, Mu X, Zhang
R, Wang Z, Zhang W, Lang J, Leng J and Jiang X: Co-cultured
endometrial stromal cells and peritoneal mesothelial cells for an
in vitro model of endometriosis. Integr Biol (Camb). 4:1090–1095.
2012. View Article : Google Scholar
|
|
23
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar
|
|
24
|
Xiang Y, Lu DL, Li JP, Yu CX, Zheng DL,
Huang X, Wang ZY, Hu P, Liao XH and Zhang TC: Myocardin inhibits
estrogen receptor alpha-mediated proliferation of human breast
cancer MCF-7 cells via regulating MicroRNA expression. IUBMB Life.
68:477–487. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao XH, Wang N, Zhao DW, Zheng DL, Zheng
L, Xing WJ, Ma WJ, Bao LY, Dong J and Zhang TC: STAT3 protein
regulates vascular smooth muscle cell phenotypic switch by
interaction with myocardin. J Biol Chem. 290:19641–19652. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang WL and Zhang JH: miR-181c promotes
proliferation via suppressing PTEN expression in inflammatory
breast cancer. Int J Oncol. 46:2011–2020. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang WL, Lv W, Sun SZ, Wu XZ and Zhang
JH: miR-206 inhibits metastasis-relevant traits by degrading MRTF-A
in anaplastic thyroid cancer. Int J Oncol. 47:133–142. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang WL, Zhang JH, Wu XZ, Yan T and Lv W:
miR-15b promotes epithelial-mesenchymal transition by inhibiting
SMURF2 in pancreatic cancer. Int J Oncol. 47:1043–1053. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liao XH, Wang N, Zhao DW, Zheng DL, Zheng
L, Xing WJ, Zhou H, Cao DS and Zhang TC: NF-κB (p65) negatively
regulates myocardin-induced cardiomyocyte hypertrophy through
multiple mechanisms. Cell Signal. 26:2738–2748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liao XH, Wang N, Liu LY, Zheng L, Xing WJ,
Zhao DW, Sun XG, Hu P, Dong J and Zhang TC: MRTF-A and STAT3
synergistically promote breast cancer cell migration. Cell Signal.
26:2370–2380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
32
|
Fu TG, Wang L, Li W, Li JZ and Li J:
miR-143 inhibits oncogenic traits by degrading NUAK2 in
glioblastoma. Int J Mol Med. 37:1627–1635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ren ZG, Dong SX, Han P and Qi J: miR-203
promotes proliferation, migration and invasion by degrading SIK1 in
pancreatic cancer. Oncol Rep. 35:1365–1374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liao XH, Li YQ, Wang N, Zheng L, Xing WJ,
Zhao DW, Yan TB, Wang Y, Liu LY, Sun XG, et al: Re-expression and
epigenetic modification of maspin induced apoptosis in MCF-7 cells
mediated by myocardin. Cell Signal. 26:1335–1346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liao XH, Wang Y, Wang N, Yan TB, Xing WJ,
Zheng L, Zhao DW, Li YQ, Liu LY, Sun XG, et al: Human chorionic
gonadotropin decreases human breast cancer cell proliferation and
promotes differentiation. IUBMB Life. 66:352–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liao XH, Xiang Y, Yu CX, Li JP, Li H, Nie
Q, Hu P, Zhou J and Zhang TC: STAT3 is required for miR-17
5p-mediated sensitization to chemotherapy-induced apoptosis in
breast cancer cells. Oncotarget. 8:15763–15774. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liao XH, Li JY, Dong XM, Wang X, Xiang Y,
Li H, Yu CX, Li JP, Yuan BY, Zhou J and Zhang TC: ERα inhibited
myocardin-induced differentiation in uterine fibroids. Exp Cell
Res. 350:73–82. 2017. View Article : Google Scholar
|
|
38
|
Yoshikawa K, Noguchi K, Nakano Y, Yamamura
M, Takaoka K, Hashimoto-Tamaoki T and Kishimoto H: The Hippo
pathway transcriptional co-activator, YAP, confers resistance to
cisplatin in human oral squamous cell carcinoma. Int J Oncol.
46:2364–2370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liao XH, Dong X, Wu C, Wang T, Liu F, Zhou
J and Zhang TC: Human cytomegalovirus immediate early protein 2
enhances myocardin-mediated survival of rat aortic smooth muscle
cells. Virus Res. 192:85–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xing WJ, Liao XH, Wang N, Zhao DW, Zheng
L, Zheng DL, Dong J and Zhang TC: MRTF-A and STAT3 promote
MDA-MB-231 cell migration via hypermethylating BRSM1. IUBMB Life.
67:202–217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
He H and Magi-Galluzzi C:
Epithelial-to-mesenchymal transition in renal neoplasms. Adv Anat
Pathol. 21:174–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Klymkowsky MW and Savagner P:
Epithelial-mesenchymal transition: A cancer researcher’s conceptual
friend and foe. Am J Pathol. 174:1588–1593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen J, Wang L, Matyunina LV, Hill CG and
McDonald JF: Overexpression of miR-429 induces
mesenchymal-to-epithelial transition (MET) in metastatic ovarian
cancer cells. Gynecol Oncol. 121:200–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Machackova T, Mlcochova H, Stanik M,
Dolezel J, Fedorko M, Pacik D, Poprach A, Svoboda M and Slaby O:
MiR-429 is linked to metastasis and poor prognosis in renal cell
carcinoma by affecting epithelial-mesenchymal transition. Tumour
Biol. 37:14653–14658. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sun Y, Shen S, Liu X, Tang H, Wang Z, Yu
Z, Li X and Wu M: MiR-429 inhibits cells growth and invasion and
regulates EMT-related marker genes by targeting Onecut2 in
colorectal carcinoma. Mol Cell Biochem. 390:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wu CL, Ho JY, Chou SC and Yu DS: MiR-429
reverses epithelial-mesenchymal transition by restoring E-cadherin
expression in bladder cancer. Oncotarget. 7:26593–26603.
2016.PubMed/NCBI
|
|
51
|
Qiu M, Liang Z, Chen L, Tan G, Wang K, Liu
L, Liu J and Chen H: MicroRNA-429 suppresses cell proliferation,
epithelial-mesenchymal transition, and metastasis by direct
targeting of BMI1 and E2F3 in renal cell carcinoma. Urol Oncol.
33:332. e9–e82015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Deng Y, Huang Z, Xu Y, Jin J, Zhuo W,
Zhang C, Zhang X, Shen M, Yan X, Wang L, et al: MiR-215 modulates
gastric cancer cell proliferation by targeting RB1. Cancer Lett.
342:27–35. 2014. View Article : Google Scholar
|
|
53
|
Xu YJ and Fan Y: MiR-215/192 participates
in gastric cancer progression. Clin Transl Oncol. 17:34–40. 2015.
View Article : Google Scholar
|
|
54
|
Scudiero DA: Decreased DNA repair
synthesis and defective colony-forming ability of ataxia
telangiectasia fibroblast cell strains treated with
N-methyl-N’-nitro-N-nitrosoguanidine. Cancer Res. 40:984–990.
1980.PubMed/NCBI
|
|
55
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fischer KR, Durrans A, Lee S, Sheng J, Li
F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al:
Epithelial-to-mesenchymal transition is not required for lung
metastasis but contributes to chemoresistance. Nature. 527:472–476.
2015. View Article : Google Scholar : PubMed/NCBI
|
